GHRP-2 5mg ×10 + MOD GRF (1-29) 5mg ×10 (Bundle)
CAS: GHRP-2: 158861-67-7 | MOD GRF (1-29): 86168-78-7
The GHRP-2 + MOD GRF (1-29) 5mg ×10 Bundle by BioPeptides is a high-purity research-grade peptide combination developed for advanced laboratory studies in growth hormone signaling, receptor interaction, and endocrine pathway analysis. This bundle includes GHRP-2 (CAS 158861-67-7) and MOD GRF (1-29) no DAC (CAS 86168-78-7), supplied in multiple 5mg vials for experimental flexibility. Purified to ≥99% HPLC, the peptides provide reliable molecular consistency for controlled biochemical and in-vitro studies. Laboratories across Europe rely on BioPeptides to buy peptides online with confidence through EU-friendly logistics and verified analytical documentation.
$1280.00
Research Use Only
GHRP-2 + MOD GRF (1-29) Research Overview
The GHRP-2 + MOD GRF (1-29) bundle combines two peptides commonly studied for their role in growth hormone signaling and endocrine regulation pathways.
GHRP-2 functions as a growth hormone secretagogue acting through ghrelin receptors, while MOD GRF (1-29) is a truncated analog of growth hormone–releasing hormone (GHRH) that stimulates pituitary receptor signaling.
The bundle format allows laboratories to explore synergistic endocrine signaling mechanisms, receptor cross-talk, and downstream hormonal pathway responses in controlled research environments.
Scientific Background of GHRP-2 & MOD GRF (1-29)
Growth hormone signaling is regulated through complex endocrine pathways involving releasing hormones and secretagogue peptides.
MOD GRF (1-29) mimics the activity of GHRH by activating pituitary receptors responsible for growth hormone release signaling.
GHRP-2 acts through ghrelin receptor activation, triggering complementary signaling cascades that influence endocrine system behavior.
Combining these peptides in laboratory research allows scientists to study receptor interaction, feedback regulation, signal amplification, and endocrine coordination.
Mechanistic Research Perspective
- Ghrelin receptor activation and secretagogue signaling pathway analysis
- GHRH receptor stimulation and pituitary signaling research
- Dual-pathway endocrine signaling investigation
- Receptor cross-talk and hormonal feedback loop modeling
- Growth hormone release signaling dynamics analysis
Primary Research Applications
Growth Hormone Release Research: The bundle is widely used to investigate GH secretion dynamics, receptor activation timing, and endocrine signaling efficiency.
Endocrine System Modeling: Researchers apply this peptide combination to study hormonal regulation and pituitary pathway coordination.
Receptor Interaction Studies: The combination allows detailed investigation of ghrelin receptor and GHRH receptor signaling mechanisms.
Cellular Signaling Research: Laboratories use this peptide bundle in cell-based assays exploring intracellular signaling cascades and molecular pathway responses.
In-Vitro & Preclinical Research Models: European research institutions incorporate this peptide bundle into controlled in-vitro models investigating endocrine signaling without therapeutic intent.
Molecular Characteristics
- Peptide Type: Growth hormone secretagogue and GHRH analog
- GHRP-2 CAS Identifier: 158861-67-7
- MOD GRF (1-29) CAS Identifier: 86168-78-7
- GHRP-2 Molecular Weight: ~817.9 g/mol
- MOD GRF (1-29) Molecular Weight: ~3357 g/mol
- Form: Lyophilized peptide powders supplied in separate vials
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C for long-term stability
- Protect vials from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles after reconstitution
- Reconstitute using sterile laboratory-grade solvent
- Handle peptides using aseptic laboratory techniques
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solutions
- Buffered aqueous laboratory solutions
- Standard biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
GHRP-2 5mg ×10 + MOD GRF (1-29) 5mg ×10 Bundle
brand
BioPeptides
cas
158861-67-7 | 86168-78-7
purity
≥99% (HPLC verified)
unit Size
5mg ×10 vials each peptide
form
Lyophilized powder (separate vials)
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Synthetic peptide hormones
stability
High when stored appropriately
Analytical Validation and Quality Assurance
- High-performance liquid chromatography (HPLC) purity verification
- Mass spectrometry molecular weight confirmation
- Structural integrity and peptide sequence validation
- Batch-to-batch consistency testing
- Peptide stability and analytical verification
Regulatory and Compliance Statement
The GHRP-2 + MOD GRF (1-29) 5mg ×10 bundle supplied by BioPeptides is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, cosmetic treatment, or therapeutic applications. Buyers must ensure compliance with applicable research regulations and institutional policies.
Frequently Asked Questions
The bundle is used in laboratory research investigating growth hormone signaling, receptor interaction, endocrine pathway coordination, and molecular response mechanisms.
MOD GRF (1-29) is a truncated analog of GHRH used in research to study shorter signaling cycles and receptor activation timing.
Researchers combine them to analyze dual-pathway GH signaling, receptor synergy, and endocrine feedback regulation mechanisms.
Yes. Each peptide is supplied in individual 5mg vials with 10 vials per peptide for flexible experimental design.
Store lyophilized peptides at −20°C and avoid repeated freeze–thaw cycles to maintain molecular stability.